Modular Medical Beheer

Beheer criteriumcontroles 3/4

De CEO Modular Medical is Jeb Besser, benoemd in Feb2022, heeft een ambtstermijn van 2.75 jaar. bezit rechtstreeks 0.42% van de aandelen van het bedrijf, ter waarde $ 243.18K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.8 jaar en 3.5 jaar.

Belangrijke informatie

Jeb Besser

Algemeen directeur

US$130.5k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.8yrs
Eigendom CEO	0.4%
Management gemiddelde ambtstermijn	2.8yrs
Gemiddelde ambtstermijn bestuur	3.5yrs

Recente managementupdates

Recent updates

Here's Why Modular Medical (NASDAQ:MODD) Must Use Its Cash Wisely

Jul 16

Here's Why We're A Bit Worried About Modular Medical's (NASDAQ:MODD) Cash Burn Situation

Oct 08

CEO

Jeb Besser (48 yo)

2.8yrs

Tenure

US$130,480

Compensatie

Mr. James E. Besser, also known as Jeb, has been Chief Executive Officer of Modular Medical, Inc. since February 23, 2022 and was its President from April 26, 2017 to July 24, 2017. He has experience in al...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Paul DiPerna	Founder	7.3yrs	US$482.79k	7.36% $ 4.3m
James Besser	Chief Executive Officer	2.8yrs	US$130.48k	0.42% $ 243.2k
Kevin Schmid	Chief Operating Officer	2.3yrs	US$410.51k	geen gegevens

2.8yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MODD wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Paul DiPerna	Founder	7.3yrs	US$482.79k	7.36% $ 4.3m
Duane DeSisto	Independent Director	1.3yrs	US$261.77k	0.28% $ 160.8k
Carmen Volkart	Independent Director	4.9yrs	US$39.97k	0.031% $ 18.2k
Steven Felsher	Independent Director	3yrs	US$40.69k	0.37% $ 214.5k
Ellen Vos	Director	3.5yrs	US$61.31k	0.053% $ 31.1k
Philip Sheibley	Independent Director	3yrs	US$44.55k	0.19% $ 111.1k
Morgan Frank	Director	7.6yrs	US$45.39k	0.59% $ 346.5k

3.5yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MODD wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Modular Medical Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Modular Medical, Inc., Annual General Meeting, Feb 13, 2024

Director recently bought US$156k worth of stock

Modular Medical, Inc. Announces Appointment of Duane DeSisto to its Board of Directors

Modular Medical, Inc., Annual General Meeting, Jan 17, 2023

High number of new directors

Modular Medical, Inc. Appoints Kevin Schmid as Chief Operating Officer

Recent updates

Modular Medical, Inc. has filed a Follow-on Equity Offering.

Modular Medical, Inc. Announces Results from a Successful GLP-1 Proof of Concept Study

Modular Medical, Inc. Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the Modd1 Platform

Modular Medical, Inc Announces FDA Clearance of the MODD1 Insulin Pump

Consensus revenue estimates decrease by 40%, EPS upgraded

Here's Why Modular Medical (NASDAQ:MODD) Must Use Its Cash Wisely

New major risk - Financial position

New major risk - Share price stability

Modular Medical, Inc. has completed a Follow-on Equity Offering in the amount of $10.000001 million.

New major risk - Financial position

Modular Medical, Inc., Annual General Meeting, Feb 13, 2024

Modular Medical, Inc. has filed a Follow-on Equity Offering in the amount of $6.5 million.

Modular Medical, Inc. has filed a Follow-on Equity Offering in the amount of $6.5 million.

Modular Medical, Inc. Updates Test Progress and Submission Timeline

Here's Why We're A Bit Worried About Modular Medical's (NASDAQ:MODD) Cash Burn Situation

Director recently bought US$156k worth of stock

Modular Medical, Inc. Announces Appointment of Duane DeSisto to its Board of Directors

New major risk - Share price stability

Modular Medical, Inc. has completed a Composite Units Offering in the amount of $9.389999 million.

Modular Medical, Inc. has completed a Composite Units Offering in the amount of $9.4 million.

Modular Medical (NASDAQ:MODD) Will Have To Spend Its Cash Wisely

Modular Medical, Inc. Provides Update on FDA Submission Strategy

Modular Medical, Inc., Annual General Meeting, Jan 17, 2023

Modular Medical, Inc. Announces Update on Development of its Initial Insulin Pump Product

We're Keeping An Eye On Modular Medical's (NASDAQ:MODD) Cash Burn Rate

High number of new directors

Modular Medical Provides Product Update

Modular Medical, Inc. Appoints Kevin Schmid as Chief Operating Officer

Modular Medical appoints Kevin Schmid as COO

We Think Modular Medical (NASDAQ:MODD) Needs To Drive Business Growth Carefully

High number of new directors

Modular Medical: Next Generation Insulin Pump Developer

Modular Medical, Inc. Announces Executive Changes

Manchester Management Engages in Discussions with Modular Medical

Modular Medical Common Stock Deleted from Other OTC

High number of new directors

Modular Medical, Inc. announced that it has received $6.56 million in funding

Modular Medical, Inc. announced that it has received $1.1 million in funding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd